Does PANOBINOSTAT Cause Hepatic function abnormal? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Hepatic function abnormal have been filed in association with PANOBINOSTAT. This represents 1.7% of all adverse event reports for PANOBINOSTAT.
31
Reports of Hepatic function abnormal with PANOBINOSTAT
1.7%
of all PANOBINOSTAT reports
20
Deaths
19
Hospitalizations
How Dangerous Is Hepatic function abnormal From PANOBINOSTAT?
Of the 31 reports, 20 (64.5%) resulted in death, 19 (61.3%) required hospitalization, and 3 (9.7%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PANOBINOSTAT. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does PANOBINOSTAT Cause?
Diarrhoea (368)
Plasma cell myeloma (279)
Platelet count decreased (192)
Death (190)
Malignant neoplasm progression (166)
Fatigue (162)
Nausea (154)
Thrombocytopenia (141)
Off label use (112)
Vomiting (109)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which PANOBINOSTAT Alternatives Have Lower Hepatic function abnormal Risk?
PANOBINOSTAT vs PANTOPRAZOLE
PANOBINOSTAT vs PANTOPRAZOLE ANHYDROUS
PANOBINOSTAT vs PANTOTHENIC ACID
PANOBINOSTAT vs PAPAVERINE
PANOBINOSTAT vs PARACETAMOL